Mitral Regurgitation Clinical Trials in Norfolk, Virginia
4 studies are recruiting for mitral regurgitation in Norfolk, Virginia right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.
Search these by distance from you
Studies now recruiting
-
Cephea Early Feasibility Study
The objective of this study is to evaluate the preliminary safety and effectiveness of the Cephea Mitral Valve System for the treatment of symptomatic patients with mitral valve disease (including mitral regurgitation, mitral stenosis and mixed mitral valve disease) in whom transcatheter therapy is…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Sentara Norfolk General Hospital, Norfolk, Virginia
- Locations
- 22 in total
- Run by
- Abbott Medical Devices
-
Abbott Cephea Mitral Valve Disease Registry
The objective of this registry is to gather clinical data on symptomatic patients with mitral valve disease, including patients with mitral regurgitation, mitral stenosis, and mixed mitral valve disease. Data collected from this registry are expected to improve our understanding of the impact of co…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Sentara Norfolk General Hospital, Norfolk, Virginia
- Locations
- 24 in total
- Run by
- Abbott Medical Devices
-
The ENCIRCLE Trial
This study will establish the safety and effectiveness of the SAPIEN M3 System in subjects with symptomatic, at least 3+ mitral regurgitation (MR) for whom commercially available surgical or transcatheter treatment options are deemed unsuitable. Following completion of enrollment, subjects will be …
- Stage
- Not phased
- Ages
- 18 and older
- Site
- Sentara Norfolk, Norfolk, Virginia
- Locations
- 68 in total
- Run by
- Edwards Lifesciences
-
The MITRAL II Pivotal Trial (Mitral Implantation of TRAnscatheter vaLves).
A prospective multicenter study enrolling high surgical risk patients with severe mitral annular calcification (MAC) and symptomatic mitral valve dysfunction (severe stenosis, ≥ moderate to severe regurgitation, or mixed ≥ moderate stenosis and ≥ regurgitation). There are 2 Arms in this study: 1) "…
- Stage
- Not phased
- Ages
- 18 and older
- Site
- The Sentara Heart Valve and Structural Disease Center, Norfolk, Virginia
- Locations
- 17 in total
- Run by
- Mayra Guerrero
How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.
What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.
Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.